Pharmabiz2h
Immuneel Therapeutics launches Qartemi, India’s first global CAR T-cell therapy for non-Hodgkin’s lymphoma
Our Bureau, Bengaluru Monday, January 20, 2025, 14:30 Hrs [IST] ...
Pharmabiz3h
Amgen receives US FDA approval for Lumakras in combo with Vectibix for chemorefractory KRAS G12C-mutated metastatic colorectal cancer
Amgen receives US FDA approval for Lumakras in combo with Vectibix for chemorefractory KRAS G12C-mutated metastatic colorectal cancer: Thousand Oaks, California Monday, January 20 ...
Pharmabiz3h
EMA recommends approval of Bluevac-3 and Syvazul BTV 3 vaccines to protect sheep against bluetongue disease
EMA recommends approval of Bluevac-3 and Syvazul BTV 3 vaccines to protect sheep against bluetongue disease: Amsterdam, The Netherlands Monday, January 20, 2025, 13:00 Hrs [IST] E ...
Pharmabiz4h
TN IPA and IDMA to hold an international symposium on ‘Dissolution and Drug Development’ at MMC Chennai on January 23
TN IPA and IDMA to hold an international symposium on ‘Dissolution and Drug Development’ at MMC Chennai on January 23: Our Bureau, Chennai Monday, January 20, 2025, 12:15 Hrs ...
Pharmabiz1h
National Institutes of Health to lead implementation of National Plan to End Parkinson’s Act
National Institutes of Health to lead implementation of National Plan to End Parkinson’s Act: Bethesda, Maryland Monday, January 20, 2025, 15:00 Hrs [IST] With support from the ...
Pharmabiz5h
Fermion and Simcere Pharma ink partnership to develop a clinical-stage pain treatment asset, FZ002-037, targeting SSTR4
Fermion and Simcere Pharma ink partnership to develop a clinical-stage pain treatment asset, FZ002-037, targeting SSTR4: Guangzhou, China Monday, January 20, 2025, 11:00 Hrs [IST] ...
Pharmabiz7h
AstraZeneca’s Calquence plus chemoimmunotherapy approved in US for patients with previously untreated mantle cell lymphoma
AstraZeneca’s Calquence plus chemoimmunotherapy approved in US for patients with previously untreated mantle cell lymphoma: Cambridge, UK Monday, January 20, 2025, 09:00 Hrs [IS ...
Pharmabiz4d
Acadia Pharma seeks European marketing approval for trofinetide for the treatment of Rett syndrome
Acadia Pharma seeks European marketing approval for trofinetide for the treatment of Rett syndrome: San Diego Thursday, January 16, 2025, 13:00 Hrs [IST] Acadia Pharmaceuticals In ...
Pharmabiz5d
Novartis Entresto US patent upheld by US Court of Appeals
Novartis, an innovative medicines company, announced that the company is pleased with the decision by the US Court of Appeals for the Federal Circuit (CAFC) that ...
Pharmabiz3d
Glaukos announces positive clinical updates for its iDose sustained-release procedural pharmaceutical platform
Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, announced several ...
Pharmabiz3d
ACT commits Rs. 8.33 crore to the future of rural healthcare in India with Khushi Baby & Medoplus
ACT, an Indian venture philanthropy platform, has committed Rs. 8.33 crore in catalytic grants to Khushi Baby and Medoplus; social startups that are pioneering tech-first solutions to revolutionise ...
Pharmabiz3d
Pasithea Therapeutics opens European clinical trial sites and completes initial dosing of cohort 4
Pasithea Therapeutics Corp., a clinical-stage biotechnology company developing PAS-004, a next-generation macrocyclic MEK inhibitor, for the treatment of neurofibromatosis type 1 (NF1) and other ...